Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Abiomed financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Revenue
$1 B
FY, 2022
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|
| Revenue | 840.9M | 847.5M | 1.0B |
| Cost of goods sold | 151.3M | 161.9M | 188.2M |
| Gross profit | 689.6M | 685.6M | 843.6M |
| Gross profit margin, % | 82.0% | 80.9% | 81.8% |
| General and administrative expense | 341.6M | 334.2M | 423.5M |
| Operating expense total | 440.4M | 456.1M | 586.9M |
| EBIT | 249.2M | 229.6M | 140.7M |
| EBIT margin, % | 29.6% | 27.1% | 13.6% |
| Investment income | 12.2M | 6.7M | |
| Pre tax profit | 256.8M | 288.2M | 190.6M |
| Income tax expense | 53.8M | 62.7M | 54.1M |
| Net Income | 203.0M | 225.5M | 136.5M |
| EPS | 4.4 | 4.9 | 3.0 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |